$5.70
0.020.35%
Last update: Nov 9, 7:16 PM
Orchestra BioMed Holdings Inc
OBIONASDAQ
Orchestra BioMed Hldgs (OBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.43 | $-0.38 | $-0.41 |
| Actual | $-0.38 | $-0.33 | $0.26 | $-0.40 |
| Surprise | -2.70% | +23.3% | +168.4% | +2.44% |
| Revenue | ||||
| Estimate | $120536 | $512664 | $871174 | $748560 |
| Actual | $88000 | $110000 | $30.9M | $861000 |
| Surprise | -27.0% | -78.5% | +3448.9% | +15.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.40 | $-0.41 | $-0.37 | $-0.37 |
| Revenue | ||||
| Consensus | $104800 | $109464 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.38 | $-0.37 | -2.70 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.43 | 23.3 % |
| Q4 | Mar 12, 2026 | $0.26 | $-0.38 | 168.4 % |
| Q3 | Nov 10, 2025 | $-0.40 | $-0.41 | 2.44 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $88.00K | $120.54K | -27.0 % |
| Q1 | May 12, 2026 | $110.00K | $512.66K | -78.5 % |
| Q4 | Mar 12, 2026 | $30.92M | $871.17K | 3448.9 % |
| Q3 | Nov 10, 2025 | $861.00K | $748.56K | 15.0 % |
